Arkema SA (OTCMKTS:ARKAY – Get Free Report) saw a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 58 shares, a drop of 96.7% from the February 12th total of 1,744 shares. Based on an average daily volume of 6,662 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s shares are sold short. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 6,662 shares, the short-interest ratio is presently 0.0 days.
Analyst Ratings Changes
A number of equities analysts have recently weighed in on ARKAY shares. Deutsche Bank Aktiengesellschaft lowered shares of Arkema from a “buy” rating to a “hold” rating in a research report on Monday, November 24th. Kepler Capital Markets cut shares of Arkema from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 27th. Zacks Research downgraded Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, January 6th. The Goldman Sachs Group raised Arkema from a “hold” rating to a “buy” rating in a research note on Tuesday, February 10th. Finally, Barclays cut Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday, November 11th. Two equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, Arkema presently has an average rating of “Reduce”.
View Our Latest Stock Report on Arkema
Arkema Trading Up 2.2%
Arkema Company Profile
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Read More
- Five stocks we like better than Arkema
- “I just bought 10,000 shares of a $5 stock…”
- Have $500? Invest in Elon’s AI Masterplan
- What a Former CIA Agent Knows About the Coming Collapse
- The gold chart Wall Street is terrified of…
- What central banks are doing with gold right now
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
